PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASE-RELATED OR DRUG-INDUCED DYSKINESIAS CONTAINING PIPERIDINE DERIVATIVES AS NMDA RECEPTOR ANTAGONIST AS ACTIVE INGREDIENT

摘要

Dyskinesias in humans are treated by administering a therapeutically effective dose of an NR1A/2B site-selective NMDA receptor antagonist compound to a human suffering therefrom.